A detailed history of Tiaa Trust, National Association transactions in Moderna, Inc. stock. As of the latest transaction made, Tiaa Trust, National Association holds 4,282 shares of MRNA stock, worth $180,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,282
Previous 4,337 1.27%
Holding current value
$180,614
Previous $515,000 44.47%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $3,500 - $6,882
-55 Reduced 1.27%
4,282 $286,000
Q2 2024

Aug 01, 2024

SELL
$101.21 - $166.61 $11,942 - $19,659
-118 Reduced 2.65%
4,337 $515,000
Q1 2024

May 10, 2024

SELL
$85.37 - $115.44 $3,073 - $4,155
-36 Reduced 0.8%
4,455 $474,000
Q4 2023

Jan 23, 2024

BUY
$69.51 - $104.43 $7,090 - $10,651
102 Added 2.32%
4,491 $446,000
Q3 2023

Oct 27, 2023

BUY
$96.41 - $126.61 $423,143 - $555,691
4,389 New
4,389 $453,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tiaa Trust, National Association Portfolio

Follow Tiaa Trust, National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa Trust, National Association, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa Trust, National Association with notifications on news.